/Data from IKS04, a CanAg-Targeting Antibody–Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models
Reviews
Join the dialogue
Submit a peer review to improve the scientific record